Browsing by Author "Goonewardene, M."

Now showing 1 - 14 of 14

Abnormal labour
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
Antenatal care:paradigm changes over the years
(Sri Lanka Medical Association, 2013) Goonewardene, M.; Dias, T.
This paper describes the antenatal care practices in Sri Lanka
Assisted vaginal breech delivery
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
Eclampsia and pre-eclampsia with severe features
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
External cephalic version
(Taylor and Francis Group, 2021) Goonewardene, M.; Padumadasa, S.
No abstract available
Instrumental vaginal delivery
(Taylor and Francis Group, 2021) Goonewardene, M.; Padumadasa, S.
No abstract available
Internal podalic version and breech extraction
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
Knowledge and awareness about gynaecological cancer
(Sri Lanka College of Obstetricians and Gynaecologists, 2003) Padumadasa, S.; Goonewardene, M.
INTRODUCTION: Gynaecological cancer (excluding breast cancer) accounts for about 10% of new cancer cases in women and 12% of cancer deaths. lack of awareness is a major factor in women with gynaecological cancer presenting to a doctor late. OBJECTIVE: to assess the knowledge and awareness about gynaecological cancer, SETTING, SUBJECTS AND METHOD: a total of 516 conse¬cutive women who attended the university gynaecology clinic at teaching hospital, mahamodera, galle during august and september 2002 were administered a pretested structured questionnaire. RESULTS: the knowledge about gynaecological cancer presenting as abnormal vaginal bleeding was poor. two-hundred and thirty six (45.8%) women thought that as one approaches menopause, irregular vaginal bleeding was normal. only 185 (35.8%) women knew that post-menopausal bleeding was abnormal. only 163 (31.5%) women knew that post-coital bleeding might be a symptom of cancer. two hundred and forty one (46.7%) women had heard about the cervix. only 89 (17.3%) knew that early marriage was a risk factor for cervical cancer while only 143 (27.7%) knew that multiple sexual partners was a risk factor for cervical cancer. only 27 (5.2%) were aware of the cervical smear. although 363 (70.3%) had heard about hormone replacement therapy (hrt), only 38 (7.4%) knew that there was an association with the occurrence of breast cancer and only 63 (12.2%) knew that there was a high risk of endometrial cancer if used inappropriately. only 134 (26.0%) women had heard about ovarian cancer. CONCLUSION: the knowledge about gynaecological cancer in women attending the university gynaecology clinic was poor. educational programmes in schools and community intervention programmes should be considered to increase the awareness about gynaecological cancer.
Obstetric emergencies a practical manual
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
The Outcome of preterm labour and preterm prelabour rupture of membranes after oral salbutamol or nifedipine SR
(Sri Lanka College of Obstetricians and Gynaecologists, 2005) Padumadasa, S.; Goonewardene, M.
RATIONALE: Preterm labour (PTL) and preterm prelabour rupture of membranes (FT - PLROM) are still a problem. Several tocolytics with varying doses have been tried in the treatment. OBJECTIVE: To compare the effectiveness and safety of oral salbutamol and nifedipine SR in the management of PTL and PT - PLROM. DESIGN AND SETTING: A randomised controlled trial from 15 May 2002 to 30 April 2003 at the University Obstetric Unit, Teaching Hospital, Galle. SUBJECTS AND METHOD: One hundred and fourteen consecutive women who presented with PT - PLROM or fulfilled the diagnostic criteria for PTL-more than one uterine contraction occurring within ten minutes and the cervix effaced and greater than 1cm, and without any contraindications for tocolysis, were randomly assigned to receive either oral salbutamol 4 mg 8 hourly or nifedipine SR 20 mg 12 hourly for 48 hours. The first author was unaware of the treatment regimen until the final analysis. Three doses of dexamethasone 8 mg 12 hourly were also given. MAIN OUTCOME MEASURES: The time interval upto delivery, birth weight of the baby, admissions to premature baby unit, perinatal deaths and adverse maternal effects were assessed. RESULTS: Forty-eight women received salbutamol and 66 received nifedipine SR. Between the two groups there were no significant differences in the basic characteristics, the mean period of gestation, the frequency of uterine contractions and the cervical dilatation in the subjects. Delivery occurred after a mean of 9.7 days SD 14.7 (salbutamol group) and 14.6 days SD 21.0 (nifedipine SR group) (P=0.2). In the salbutamol group 75% delivered within 9.5 days while in the Nifedipine SR group it took 28.0 days for 75% of the subjects to deliver. The mean birth weight of the babies in the nifedipine SR group (2.47 kg, SD 0.68) was significantly higher (P=0.04) than that of the babies in the salbutamol group (2.18 kg, SD 0.67). There were six perinatal deaths in the salbutamol group but only two deaths in the nifedipine SR group (P=0.06). Adverse effects were more common with salbutamol; tremors (54% versus 5%), palpitations was significantly higher (P=0.04) than that of the babies in the salbutamol group (2.18 kg, SD 0.67). There were six perinatal deaths in the salbutamol group but only two deaths in the nifedipine SR group (P=0.06). Adverse effects were more common with salbutamol; tremors (54% versus 5%), palpitations (46% versus 9%), nausea (10% versus 5%) compared to nifedipine SR. Headache was commoner with nifedipine SR (26% versus 10%). CONCLUSIONS: If oral to colytics are used in women with preterm labour or preterm prelabour rupture of membranes nifedipine SR is apparently better than salbutamol with regard to adverse maternal effects. There may be a delay in delivery and an increase of the birth weight of the baby with nifedipine SR treatment. (46% versus 9%), nausea (10% versus 5%) compared to nifedipine SR. Headache was commoner with nifedipine SR (26% versus 10%). CONCLUSIONS: If oral tocolytics are used in women with preterm labour or preterm prelabour rupture of membranes nifedipine SR is apparently better than salbutamol with regard to adverse maternal effects. There may be a delay in delivery and an increase of the birth weight of the baby with nifedipine SR treatment.
Overview of obstetric emergencies
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
Primary postpartum haemorrhage
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
Shoulder dystocia
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available
Twin delivery
(Taylor and Francis Group, 2021) Padumadasa, S.; Goonewardene, M.
No abstract available